Xyntek Completes Serialisation Deployment in Record Setting 10 Days

Xyntek Completes Serialisation Deployment in Record Setting 10 Days to Support Seasonal Vaccine Production

Dec 20th 2019

Xyntek Inc has completed the  fastest deployment of a serialised packaging line to support the production of the seasonal Influenza Vaccine, in order to adhere to the  Drug Supply Chain Security Act. From receipt of Purchase Order, Xyntek designed, configured, integrated, and validated three modules for the Unit, Case, and Pallet serialisation and aggregation, all within 10 business days.  This timeline is a significant reduction from a typical serialisation deployment, which can take from 16 weeks to upwards of 10 months.

Essential serialisation equipment needed to adhere to the Drug Supply Chain Security Act.

Xyntek leveraged its extensive experience in serialisation consulting, detailed design engineering, system programming & configuration, installation, and validation, in order to achieve this incredibly unprecedented and rapid project timeline. Xyntek is the North America limited exclusive, long time partner of Antares Vision since August 2012, a global leader in serialisation hardware and software, and leverages this close partnership in order to be able to provide unrivalled service in the U.S. pharmaceutical serialisation market.

The rapid deployment of this line was essential for a major pharmaceutical manufacturing customer that had an urgent need in order to produce seasonal Flu Vaccine products, which require serialisation under the DSCSA. With the equipment successfully designed, configured, deployed, and validated on time, the customer was able to fulfill the customer request and deliver more than 3 million doses by year end.

“I am incredibly proud of our team and how they were able to deliver this critical project in an unprecedented and extremely short timeframe. Since 2012, we have delivered hundreds of Serialised automated pharmaceutical packaging lines, which enabled us to execute so rapidly,” explains Mac Hashemian, P.E., CEO of Xyntek, Inc.